MED
Medifast, Inc. NYSE Listed Dec 30, 1993$12.70
Mkt Cap $141.2M
52w Low $9.22
55.8% of range
52w High $15.46
50d MA $10.52
200d MA $11.94
P/E (TTM)
-6.4x
EV/EBITDA
-12.1x
P/B
0.6x
Debt/Equity
0.1x
ROE
-9.4%
P/FCF
93.9x
RSI (14)
—
ATR (14)
—
Beta
0.56
50d MA
$10.52
200d MA
$11.94
Avg Volume
254.3K
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
100 International Drive · Baltimore, MD 21202 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.55 | -0.19 | +65.5% | 10.63 | -5.9% | +22.5% | -2.5% | +0.0% | — | — | — |
| Feb 17, 2026 | AMC | -0.76 | -0.55 | +27.6% | 10.80 | -2.8% | -0.8% | -0.8% | +0.1% | -0.3% | -1.1% | — |
| Nov 3, 2025 | AMC | -0.01 | -0.21 | -2000.0% | 11.88 | -3.5% | +0.8% | +1.7% | -3.1% | +1.1% | -1.2% | — |
| Aug 4, 2025 | AMC | -0.30 | 0.04 | +113.3% | 13.51 | +0.0% | -3.3% | -0.8% | -1.7% | +0.9% | -0.2% | — |
| Apr 28, 2025 | AMC | -0.07 | -0.11 | -57.1% | 12.58 | -4.4% | -0.6% | +5.1% | -1.2% | +2.1% | -1.1% | — |
| Feb 18, 2025 | AMC | -0.16 | 0.10 | +162.5% | 16.13 | -2.0% | -11.4% | +0.3% | +2.8% | +0.3% | -2.6% | — |
| Nov 4, 2024 | AMC | -0.15 | 0.35 | +333.3% | 18.81 | +10.6% | +8.5% | -3.4% | +0.9% | -3.6% | +1.4% | — |
| Aug 5, 2024 | AMC | 0.36 | 0.92 | +155.6% | 20.86 | -6.5% | -2.8% | -1.8% | -0.8% | -1.1% | -1.1% | — |
| Apr 29, 2024 | AMC | 0.78 | 0.66 | -15.4% | 35.51 | -25.1% | -22.5% | -4.2% | -1.6% | +2.9% | -5.7% | — |
| Feb 20, 2024 | AMC | 0.99 | 1.09 | +10.1% | 48.93 | -9.1% | -17.5% | -0.9% | +1.8% | -0.4% | +2.9% | — |
| Nov 6, 2023 | AMC | 1.07 | 2.12 | +98.1% | 70.66 | -2.2% | -2.5% | -4.3% | -1.6% | +0.9% | -4.9% | — |
| Aug 7, 2023 | AMC | 1.44 | 2.77 | +92.4% | 96.09 | +4.1% | -6.9% | +3.7% | -1.4% | +2.7% | -1.5% | — |
| May 1, 2023 | AMC | 2.40 | 3.67 | +52.9% | 90.57 | -6.4% | -2.7% | -3.4% | +3.4% | +3.2% | -1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $10.71 | $10.50 | -2.0% | -0.8% | +0.1% | -0.3% | -1.1% | +1.6% |
| Feb 19 | DA Davidson | Maintains | Neutral → Neutral | — | $16.13 | $15.80 | -2.0% | -11.4% | +0.3% | +2.8% | +0.3% | -2.6% |
| Nov 5 | DA Davidson | Upgrade | Underperform → Neutral | — | $18.81 | $20.80 | +10.6% | +8.5% | -3.4% | +0.9% | -3.6% | +1.4% |
| Jul 22 | DA Davidson | Maintains | Underperform → Underperform | — | $18.64 | $18.81 | +0.9% | +1.4% | -0.9% | +0.6% | +3.7% | +4.9% |
| Jun 5 | DA Davidson | Downgrade | Neutral → Underperform | — | $23.97 | $20.43 | -14.8% | -8.1% | -0.8% | -1.8% | -1.9% | +2.0% |
| Apr 30 | DA Davidson | Maintains | Neutral → Neutral | — | $35.51 | $26.60 | -25.1% | -22.5% | -4.2% | -1.6% | +2.9% | -5.7% |
| Feb 21 | DA Davidson | Maintains | Neutral → Neutral | — | $48.93 | $44.49 | -9.1% | -17.5% | -0.9% | +1.8% | -0.4% | +2.9% |
| Aug 8 | DA Davidson | Maintains | Neutral → Neutral | — | $96.09 | $100.00 | +4.1% | -6.9% | +3.7% | -1.4% | +2.7% | -1.5% |
| Jul 31 | DA Davidson | Maintains | Neutral → Neutral | — | $107.06 | $107.40 | +0.3% | -4.8% | -1.9% | +1.3% | -0.9% | -1.6% |
| May 2 | DA Davidson | Maintains | Neutral → Neutral | — | $90.57 | $84.77 | -6.4% | -2.7% | -3.4% | +3.4% | +3.2% | -1.4% |
| Feb 22 | DA Davidson | Maintains | Neutral → Neutral | — | $105.44 | $101.10 | -4.1% | -2.4% | +5.6% | +1.3% | +1.6% | +0.4% |
| Nov 4 | DA Davidson | Downgrade | Buy → Neutral | — | $103.38 | $96.37 | -6.8% | +4.1% | -0.7% | +2.3% | -4.7% | +10.1% |
| Aug 4 | Jefferies | Downgrade | Buy → Hold | — | $171.60 | $150.54 | -12.3% | -13.7% | -6.3% | -1.7% | -7.7% | +2.0% |
| Aug 4 | DA Davidson | Maintains | Buy → Buy | — | $171.60 | $150.54 | -12.3% | -13.7% | -6.3% | -1.7% | -7.7% | +2.0% |
| Jun 2 | DA Davidson | Maintains | Buy → Buy | — | $174.81 | $180.36 | +3.2% | +8.4% | -2.8% | +0.0% | +2.8% | +0.0% |
| Feb 24 | DA Davidson | Maintains | Buy → Buy | — | $176.16 | $169.56 | -3.7% | -2.0% | +3.1% | +4.5% | +3.7% | -0.2% |
| Nov 8 | DA Davidson | Maintains | Buy → Buy | — | $222.19 | $222.20 | +0.0% | -1.1% | +2.0% | -0.7% | +2.6% | -0.5% |
| May 5 | DA Davidson | Maintains | Buy → Buy | — | $225.00 | $248.78 | +10.6% | +12.1% | +5.8% | +4.2% | +5.9% | -0.2% |
| Feb 26 | DA Davidson | Maintains | Buy → Buy | — | $254.75 | $250.35 | -1.7% | -0.7% | +5.1% | -1.7% | -2.7% | -5.8% |
| Jan 25 | Jefferies | Upgrade | Hold → Buy | — | $220.87 | $227.34 | +2.9% | +8.7% | +1.2% | -1.0% | -1.2% | -1.2% |
| Jan 12 | DA Davidson | Maintains | Buy → Buy | — | $207.43 | $208.00 | +0.3% | +0.6% | +2.4% | +1.0% | -3.3% | +6.4% |
| Nov 5 | DA Davidson | Upgrade | Neutral → Buy | — | $160.90 | $167.73 | +4.2% | +4.7% | +3.0% | -7.7% | +1.9% | +4.2% |
| Jun 25 | B. Riley FBR | Maintains | Buy → Buy | — | $123.01 | $124.68 | +1.4% | +6.5% | +0.4% | +3.8% | +1.6% | +1.8% |
| May 6 | DA Davidson | Maintains | Neutral → Neutral | — | $75.33 | $82.86 | +10.0% | +15.6% | +5.4% | +4.1% | -5.3% | -3.9% |
| Feb 27 | DA Davidson | Maintains | Neutral → Neutral | — | $94.48 | $81.11 | -14.2% | -9.2% | -3.2% | -1.0% | -1.5% | +1.8% |
| Nov 8 | DA Davidson | Downgrade | Buy → Neutral | — | $102.00 | $67.00 | -34.3% | -27.1% | +8.4% | -0.9% | +0.1% | -4.2% |
| Jul 25 | Jefferies | Maintains | Buy → Buy | — | $113.22 | $114.36 | +1.0% | +1.5% | -0.3% | -1.4% | -0.8% | -0.3% |
| Feb 27 | Sidoti & Co. | Maintains | Buy → Buy | — | $131.72 | $141.00 | +7.0% | -2.3% | -1.0% | -0.7% | +1.7% | +3.2% |
| Nov 8 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $153.31 | $156.98 | +2.4% | +0.8% | +3.4% | -1.2% | +2.6% | -3.4% |
| May 24 | DA Davidson | Maintains | Buy → Buy | — | $136.80 | $138.98 | +1.6% | +3.0% | -0.2% | +2.2% | +1.8% | +0.2% |
| Apr 19 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $102.84 | $102.11 | -0.7% | -5.6% | +1.9% | -0.9% | +1.8% | +0.0% |
| Sep 15 | DA Davidson | Maintains | Buy → Buy | — | $54.82 | $56.00 | +2.2% | +3.0% | +2.9% | -0.8% | -0.2% | -2.3% |
| Aug 17 | DA Davidson | Maintains | Buy → Buy | — | $51.63 | $51.98 | +0.7% | +8.0% | +0.1% | -0.3% | +0.2% | -0.9% |
| Jan 29 | Wunderlich | Maintains | Hold → Hold | — | $28.68 | $28.42 | -0.9% | +1.2% | -0.8% | +0.3% | -3.2% | -1.0% |
| Nov 30 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $31.84 | $30.85 | -3.1% | -4.8% | -1.0% | +1.1% | -1.5% | -0.1% |
| Oct 5 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $27.02 | $28.03 | +3.7% | +7.3% | -2.9% | +2.6% | -0.1% | -0.1% |
| Mar 3 | BofA Securities | Downgrade | Neutral → Underperform | — | $32.35 | $32.11 | -0.7% | -1.3% | +0.1% | -1.9% | -0.0% | -0.3% |
| Mar 3 | Bank of America | Downgrade | Neutral → Underperform | — | $32.35 | $32.11 | -0.7% | -1.3% | +0.1% | -1.9% | -0.0% | -0.3% |
| Nov 7 | Imperial Capital | Downgrade | Outperform → In Line | — | $32.81 | $30.58 | -6.8% | -9.3% | +0.7% | -1.4% | +2.0% | -1.2% |
| Nov 6 | Canaccord Genuity | Maintains | Hold → Hold | — | $30.09 | $31.26 | +3.9% | +9.0% | -9.3% | +0.7% | -1.4% | +2.0% |
| Aug 11 | Imperial Capital | Maintains | Outperform → Outperform | — | $26.15 | $26.24 | +0.3% | +2.8% | -2.3% | +0.3% | +2.2% | +0.8% |
| Jun 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $32.26 | $32.43 | +0.5% | +2.0% | +3.4% | +0.2% | -1.3% | -1.3% |
| Apr 23 | Imperial Capital | Maintains | Outperform → Outperform | — | $32.77 | $32.90 | +0.4% | -1.3% | +0.8% | -2.8% | -0.6% | -0.3% |
| Sep 6 | Imperial Capital | Maintains | Outperform → Outperform | — | $25.77 | $26.24 | +1.8% | -1.0% | +2.5% | -0.8% | -0.7% | +1.2% |
| Mar 26 | Wedbush | Maintains | Outperform → Outperform | — | $22.64 | $22.64 | +0.0% | -0.9% | -0.3% | +2.5% | -3.0% | +4.0% |
| Dec 19 | Canaccord Genuity | Maintains | Hold → Hold | — | $31.25 | $31.57 | +1.0% | +1.5% | +0.7% | -7.1% | -1.1% | -13.1% |
| Dec 19 | Wedbush | Maintains | Outperform → Outperform | — | $31.25 | $31.57 | +1.0% | +1.5% | +0.7% | -7.1% | -1.1% | -13.1% |
| Aug 20 | Wedbush | Maintains | Outperform → Outperform | — | $28.87 | $28.86 | -0.0% | -1.2% | -1.9% | +1.0% | -1.2% | +0.9% |
| May 9 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $17.87 | $15.56 | -12.9% | -6.5% | +4.1% | +4.5% | +0.1% | -0.2% |
| May 9 | Wedbush | Maintains | Outperform → Outperform | — | $17.87 | $15.56 | -12.9% | -6.5% | +4.1% | +4.5% | +0.1% | -0.2% |
No insider trades available.
8-K · 2.02
!! High
Medifast, Inc. -- 8-K 2.02: Earnings Results
Medifast reported first-quarter 2026 earnings, providing investors with updated financial performance metrics and operational results for the company's direct-to-consumer weight-loss business segment.
May 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
New leadership at MED could signal strategic shifts in operations and capital allocation, making it crucial for investors to assess whether the replacement strengthens or weakens management quality.
Mar 20
8-K
Medifast, Inc. -- 8-K Filing
Medifast's return to positive coach productivity growth in Q4 2025 signals potential recovery momentum, as this metric historically precedes broader business improvement for the direct-sales wellness company.
Feb 17
Data updated apr 26, 2026 11:47am
· Source: massive.com